Mirae Asset Global Etfs Holdings Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 178,114 shares of RCKT stock, worth $447,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,114
Previous 177,548
0.32%
Holding current value
$447,066
Previous $2.23 Million
46.75%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$44.4 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$31.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$15.5 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$13.1 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $190M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...